Drug labeling for mifepristone and misoprostol indicates that approximately 1 in 25 women who use chemical abortion drugs require emergency room care, and some experience hemorrhaging, infection, or require surgery.
high
general
Safety information reported on medication labeling for medical abortion.
Mifepristone drug labeling states that roughly 1 in 25 women who take chemical abortion drugs end up in the emergency room, and many experience hemorrhaging, infection, or require surgery.
high
statistical
Safety information as stated on mifepristone product labeling